<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6716476</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">31507370</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6716476</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fnins.2019.00899</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>TABLE 1</table-label><table-caption>Demographic and clinical characteristics of neonates divided according to the NICI score categories.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>TABLE 1</label><caption><p>Demographic and clinical characteristics of neonates divided according to the NICI score categories.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="justify" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"><bold>Control-group</bold></td><td valign="top" align="center" colspan="3" rowspan="1"><bold>IP-group</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic></bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" colspan="3" rowspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1"><bold>NICI score</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>I</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>II</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>III</bold></td><td rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="justify" rowspan="1" colspan="1">N° neonates</td><td valign="top" align="center" rowspan="1" colspan="1">13</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Gestational age (week) <italic>Median (range)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">31.2 (27.1–32.8)</td><td valign="top" align="center" rowspan="1" colspan="1">28.2 (27.3–29.1)</td><td valign="top" align="center" rowspan="1" colspan="1">27.1 (26.3–30.2)</td><td valign="top" align="center" rowspan="1" colspan="1">27.9 (25.3–31.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.085</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Postmenstrual age at MRI (week) <italic>Median (range)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">40.1 (39.1–41.2)</td><td valign="top" align="center" rowspan="1" colspan="1">40.1 (39.3–40.3)</td><td valign="top" align="center" rowspan="1" colspan="1">40.8 (38.9–41.3)</td><td valign="top" align="center" rowspan="1" colspan="1">40.3 (39.4–41.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.832</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Birth weight (gr) <italic>Median (range)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">1189.25 (863.81–1514.21)</td><td valign="top" align="center" rowspan="1" colspan="1">1090.88 (844.32–1427.32)</td><td valign="top" align="center" rowspan="1" colspan="1">1060.18 (713.41–1523.78)</td><td valign="top" align="center" rowspan="1" colspan="1">1190.21 (756.54–1497.59)</td><td valign="top" align="center" rowspan="1" colspan="1">0.743</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Gender <italic>N</italic>°<italic>neonates (%)</italic></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.833</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">5 (38%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (57%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (40%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (50%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">8 (62%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (43%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (60%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (50%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">APGAR 1’ <italic>Median (range)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">8.81 (5–10)</td><td valign="top" align="center" rowspan="1" colspan="1">6.97 (5–9)</td><td valign="top" align="center" rowspan="1" colspan="1">6.43 (5–8)</td><td valign="top" align="center" rowspan="1" colspan="1">6.58 (5–7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.011</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">APGAR 5’ <italic>Median (range)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">9.15 (7–10)</td><td valign="top" align="center" rowspan="1" colspan="1">8.91 (7–10)</td><td valign="top" align="center" rowspan="1" colspan="1">8.21 (6–9)</td><td valign="top" align="center" rowspan="1" colspan="1">7.22 (6–8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Days of mechanical ventilation <italic>Median (range)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (0–4)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (2–15)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (3–21)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Morphine dose<sup>∗</sup><italic>Median (range); N</italic>° <italic>neonates</italic></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0); 0</td><td valign="top" align="center" rowspan="1" colspan="1">0.15 (0.13–0.19); 4</td><td valign="top" align="center" rowspan="1" colspan="1">1.8 (0.51–3.9); 16</td><td valign="top" align="center" rowspan="1" colspan="1">2.93 (0.6–10.5); 6</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Midazolam dose<sup>∗</sup><italic>Median (range); N</italic>°<italic>neonates</italic></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0); 0</td><td valign="top" align="center" rowspan="1" colspan="1">1.2 (1–3.5); 4</td><td valign="top" align="center" rowspan="1" colspan="1">2.3 (1.5–6.7); 7</td><td valign="top" align="center" rowspan="1" colspan="1">6.5 (3.9–11.7); 5</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Dexamethasone<sup>∗</sup> dose <italic>Median (range); N</italic>°<italic>neonates</italic></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0); 0</td><td valign="top" align="center" rowspan="1" colspan="1">0.94 (0.8–1.2); 3</td><td valign="top" align="center" rowspan="1" colspan="1">0.88 (0.7–1.2); 7</td><td valign="top" align="center" rowspan="1" colspan="1">1.2 (0.75–2.1); 4</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Total skin breaks <italic>Median (range)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">1 (1–3)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (5–12)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (7–19)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (9–41)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Endotracheal intubation <italic>N</italic>°<italic>neonates (%)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0%)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0%)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (100%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (100%)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1">Surgery <italic>N</italic>°<italic>neonates (%)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0%)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0%)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (100%)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><attrib><italic>P indicates significance level of statistic comparisons. Continuous and categorical measures were compared using the Kruskall-Wallis and X<sup>2</sup> tests, respectively. Control group, neonates not requiring invasive procedures; IP group, neonates requiring invasive procedures. NICI score, neonatal intensive care invasiveness score. <sup>∗</sup> Cumulative dose in milligrams adjusted for daily body weight (Kg).</italic></attrib></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics of neonates divided according to the NICI score categories.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="justify"/><td valign="top" align="center">Control-group</td><td valign="top" align="center" colspan="3">IP-group</td><td valign="top" align="center">P</td></tr><tr><td valign="top" align="left"/><td valign="top" align="left"/><td valign="top" align="left" colspan="3"/><td valign="top" align="left"/></tr><tr><td valign="top" align="justify">NICI score</td><td valign="top" align="center">0</td><td valign="top" align="center">I</td><td valign="top" align="center">II</td><td valign="top" align="center">III</td><td/></tr></thead><tbody><tr><td valign="top" align="justify">N° neonates</td><td valign="top" align="center">13</td><td valign="top" align="center">7</td><td valign="top" align="center">20</td><td valign="top" align="center">6</td><td/></tr><tr><td valign="top" align="justify">Gestational age (week) Median (range)</td><td valign="top" align="center">31.2 (27.1–32.8)</td><td valign="top" align="center">28.2 (27.3–29.1)</td><td valign="top" align="center">27.1 (26.3–30.2)</td><td valign="top" align="center">27.9 (25.3–31.7)</td><td valign="top" align="center">0.085</td></tr><tr><td valign="top" align="justify">Postmenstrual age at MRI (week) Median (range)</td><td valign="top" align="center">40.1 (39.1–41.2)</td><td valign="top" align="center">40.1 (39.3–40.3)</td><td valign="top" align="center">40.8 (38.9–41.3)</td><td valign="top" align="center">40.3 (39.4–41.9)</td><td valign="top" align="center">0.832</td></tr><tr><td valign="top" align="justify">Birth weight (gr) Median (range)</td><td valign="top" align="center">1189.25 (863.81–1514.21)</td><td valign="top" align="center">1090.88 (844.32–1427.32)</td><td valign="top" align="center">1060.18 (713.41–1523.78)</td><td valign="top" align="center">1190.21 (756.54–1497.59)</td><td valign="top" align="center">0.743</td></tr><tr><td valign="top" align="justify">Gender N°neonates (%)</td><td/><td/><td/><td/><td valign="top" align="center">0.833</td></tr><tr><td valign="top" align="justify">Male</td><td valign="top" align="center">5 (38%)</td><td valign="top" align="center">4 (57%)</td><td valign="top" align="center">8 (40%)</td><td valign="top" align="center">3 (50%)</td><td/></tr><tr><td valign="top" align="justify">Female</td><td valign="top" align="center">8 (62%)</td><td valign="top" align="center">3 (43%)</td><td valign="top" align="center">12 (60%)</td><td valign="top" align="center">3 (50%)</td><td/></tr><tr><td valign="top" align="justify">APGAR 1’ Median (range)</td><td valign="top" align="center">8.81 (5–10)</td><td valign="top" align="center">6.97 (5–9)</td><td valign="top" align="center">6.43 (5–8)</td><td valign="top" align="center">6.58 (5–7)</td><td valign="top" align="center">0.011</td></tr><tr><td valign="top" align="justify">APGAR 5’ Median (range)</td><td valign="top" align="center">9.15 (7–10)</td><td valign="top" align="center">8.91 (7–10)</td><td valign="top" align="center">8.21 (6–9)</td><td valign="top" align="center">7.22 (6–8)</td><td valign="top" align="center">0.003</td></tr><tr><td valign="top" align="justify">Days of mechanical ventilation Median (range)</td><td valign="top" align="center">0 (0)</td><td valign="top" align="center">2 (0–4)</td><td valign="top" align="center">6 (2–15)</td><td valign="top" align="center">9 (3–21)</td><td valign="top" align="center">&lt;0.001</td></tr><tr><td valign="top" align="justify">Morphine dose∗Median (range); N° neonates</td><td valign="top" align="center">0 (0); 0</td><td valign="top" align="center">0.15 (0.13–0.19); 4</td><td valign="top" align="center">1.8 (0.51–3.9); 16</td><td valign="top" align="center">2.93 (0.6–10.5); 6</td><td valign="top" align="center">&lt;0.001</td></tr><tr><td valign="top" align="justify">Midazolam dose∗Median (range); N°neonates</td><td valign="top" align="center">0 (0); 0</td><td valign="top" align="center">1.2 (1–3.5); 4</td><td valign="top" align="center">2.3 (1.5–6.7); 7</td><td valign="top" align="center">6.5 (3.9–11.7); 5</td><td valign="top" align="center">&lt;0.001</td></tr><tr><td valign="top" align="justify">Dexamethasone∗ dose Median (range); N°neonates</td><td valign="top" align="center">0 (0); 0</td><td valign="top" align="center">0.94 (0.8–1.2); 3</td><td valign="top" align="center">0.88 (0.7–1.2); 7</td><td valign="top" align="center">1.2 (0.75–2.1); 4</td><td valign="top" align="center">&lt;0.001</td></tr><tr><td valign="top" align="justify">Total skin breaks Median (range)</td><td valign="top" align="center">1 (1–3)</td><td valign="top" align="center">9 (5–12)</td><td valign="top" align="center">13 (7–19)</td><td valign="top" align="center">28 (9–41)</td><td valign="top" align="center">&lt;0.001</td></tr><tr><td valign="top" align="justify">Endotracheal intubation N°neonates (%)</td><td valign="top" align="center">0 (0%)</td><td valign="top" align="center">0 (0%)</td><td valign="top" align="center">20 (100%)</td><td valign="top" align="center">6 (100%)</td><td valign="top" align="center">&lt;0.001</td></tr><tr><td valign="top" align="justify">Surgery N°neonates (%)</td><td valign="top" align="center">0 (0%)</td><td valign="top" align="center">0 (0%)</td><td valign="top" align="center">0 (0%)</td><td valign="top" align="center">6 (100%)</td><td valign="top" align="center">&lt;0.001</td></tr></tbody></table></div>P indicates significance level of statistic comparisons. Continuous and categorical measures were compared using the Kruskall-Wallis and X2 tests, respectively. Control group, neonates not requiring invasive procedures; IP group, neonates requiring invasive procedures. NICI score, neonatal intensive care invasiveness score. ∗ Cumulative dose in milligrams adjusted for daily body weight (Kg).</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>TABLE 2</table-label><table-caption>Clinical outcome at 24 months and NICI score categories.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>TABLE 2</label><caption><p>Clinical outcome at 24 months and NICI score categories.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="center" colspan="2" rowspan="1"><bold>NICI score</bold></td><td valign="top" align="center" colspan="6" rowspan="1"><bold>Griffith’s developmental scale scores (mean ± std.dev)</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" colspan="6" rowspan="1"><hr/></td></tr><tr><td valign="top" colspan="2" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"><bold>Developmental quotient</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Locomotor</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Personal-social</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Hearing-speech</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Eye-hand coordination</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Performance</bold></td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Control group</td><td valign="top" align="left" rowspan="1" colspan="1">0 category <italic>N</italic> = 13</td><td valign="top" align="center" rowspan="1" colspan="1">101.3 ± 3.1</td><td valign="top" align="center" rowspan="1" colspan="1">101.5 ± 3.2</td><td valign="top" align="center" rowspan="1" colspan="1">98.9 ± 4.2</td><td valign="top" align="center" rowspan="1" colspan="1">101.9 ± 3.6</td><td valign="top" align="center" rowspan="1" colspan="1">101.9 ± 3.7</td><td valign="top" align="center" rowspan="1" colspan="1">99.9 ± 3.1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IP group</td><td valign="top" align="left" rowspan="1" colspan="1">I category <italic>N</italic> = 7</td><td valign="top" align="center" rowspan="1" colspan="1">98.4 ± 10.1</td><td valign="top" align="center" rowspan="1" colspan="1">99.1 ± 5.7</td><td valign="top" align="center" rowspan="1" colspan="1">90.1 ± 9.2</td><td valign="top" align="center" rowspan="1" colspan="1">94.2 ± 9.6</td><td valign="top" align="center" rowspan="1" colspan="1">91.3 ± 8.4</td><td valign="top" align="center" rowspan="1" colspan="1">94.7 ± 7.2</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">II category <italic>N</italic> = 20</td><td valign="top" align="center" rowspan="1" colspan="1">90.2 ± 10.9</td><td valign="top" align="center" rowspan="1" colspan="1">93.1 ± 11.2</td><td valign="top" align="center" rowspan="1" colspan="1">87.6 ± 9.3</td><td valign="top" align="center" rowspan="1" colspan="1">94.1 ± 7.4</td><td valign="top" align="center" rowspan="1" colspan="1">90.1 ± 9.2</td><td valign="top" align="center" rowspan="1" colspan="1">92.5 ± 8.5</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">III category <italic>N</italic> = 6</td><td valign="top" align="center" rowspan="1" colspan="1">87.8 ± 8.3<sup>∗</sup></td><td valign="top" align="center" rowspan="1" colspan="1">84.5 ± 5.3<sup>∗</sup></td><td valign="top" align="center" rowspan="1" colspan="1">83.5 ± 8.3<sup>∗</sup></td><td valign="top" align="center" rowspan="1" colspan="1">86.8 ± 4.6<sup>∗</sup></td><td valign="top" align="center" rowspan="1" colspan="1">86.7 ± 4.1<sup>∗</sup></td><td valign="top" align="center" rowspan="1" colspan="1">87.8 ± 3.1<sup>∗</sup></td></tr></tbody></table><table-wrap-foot><attrib><italic>Significant lower values were observed for each subscale score in neonates of III Invasiveness score category when compared with controls. <sup>∗</sup> indicate <italic>P</italic> &lt; 0.001 (Bonferroni corrected); differences of Griffith’s developmental subscale score mean values were testes among the NICI score categories using a general linear regression model, controlling for gestational age and gender. Control group, neonates not requiring invasive procedures; IP group, neonates requiring invasive procedures; NICI score, neonatal intensive care invasiveness score: <italic>0 category</italic>, no painful events during the early post-natal period or &lt;5 skin breaks (i.e., heel lances, central line insertion, and intramuscular injection); <italic>I category</italic>, &gt;5 skin breaks or neonatal endotracheal intubation; <italic>II category</italic>, &gt;5 skin breaks and neonatal endotracheal intubation; <italic>III category</italic>, surgical interventions (i.e., patent ductus arteriosus ligation and surgical necrotizing enterocolitis).</italic></attrib></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Clinical outcome at 24 months and NICI score categories.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="center" colspan="2">NICI score</td><td valign="top" align="center" colspan="6">Griffith’s developmental scale scores (mean ± std.dev)</td></tr><tr><td valign="top" align="left"/><td valign="top" align="left"/><td valign="top" align="left" colspan="6"/></tr><tr><td valign="top" colspan="2"/><td valign="top" align="center">Developmental quotient</td><td valign="top" align="center">Locomotor</td><td valign="top" align="center">Personal-social</td><td valign="top" align="center">Hearing-speech</td><td valign="top" align="center">Eye-hand coordination</td><td valign="top" align="center">Performance</td></tr></thead><tbody><tr><td valign="top" align="left">Control group</td><td valign="top" align="left">0 category N = 13</td><td valign="top" align="center">101.3 ± 3.1</td><td valign="top" align="center">101.5 ± 3.2</td><td valign="top" align="center">98.9 ± 4.2</td><td valign="top" align="center">101.9 ± 3.6</td><td valign="top" align="center">101.9 ± 3.7</td><td valign="top" align="center">99.9 ± 3.1</td></tr><tr><td valign="top" align="left">IP group</td><td valign="top" align="left">I category N = 7</td><td valign="top" align="center">98.4 ± 10.1</td><td valign="top" align="center">99.1 ± 5.7</td><td valign="top" align="center">90.1 ± 9.2</td><td valign="top" align="center">94.2 ± 9.6</td><td valign="top" align="center">91.3 ± 8.4</td><td valign="top" align="center">94.7 ± 7.2</td></tr><tr><td/><td valign="top" align="left">II category N = 20</td><td valign="top" align="center">90.2 ± 10.9</td><td valign="top" align="center">93.1 ± 11.2</td><td valign="top" align="center">87.6 ± 9.3</td><td valign="top" align="center">94.1 ± 7.4</td><td valign="top" align="center">90.1 ± 9.2</td><td valign="top" align="center">92.5 ± 8.5</td></tr><tr><td/><td valign="top" align="left">III category N = 6</td><td valign="top" align="center">87.8 ± 8.3∗</td><td valign="top" align="center">84.5 ± 5.3∗</td><td valign="top" align="center">83.5 ± 8.3∗</td><td valign="top" align="center">86.8 ± 4.6∗</td><td valign="top" align="center">86.7 ± 4.1∗</td><td valign="top" align="center">87.8 ± 3.1∗</td></tr></tbody></table></div>Significant lower values were observed for each subscale score in neonates of III Invasiveness score category when compared with controls. ∗ indicate P &lt; 0.001 (Bonferroni corrected); differences of Griffith’s developmental subscale score mean values were testes among the NICI score categories using a general linear regression model, controlling for gestational age and gender. Control group, neonates not requiring invasive procedures; IP group, neonates requiring invasive procedures; NICI score, neonatal intensive care invasiveness score: 0 category, no painful events during the early post-natal period or &lt;5 skin breaks (i.e., heel lances, central line insertion, and intramuscular injection); I category, &gt;5 skin breaks or neonatal endotracheal intubation; II category, &gt;5 skin breaks and neonatal endotracheal intubation; III category, surgical interventions (i.e., patent ductus arteriosus ligation and surgical necrotizing enterocolitis).</transformed-table></extracted-table><extracted-table><table-id>T3</table-id><table-label>TABLE 3</table-label><table-caption>Group differences in functional connectivity.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T3" position="float"><label>TABLE 3</label><caption><p>Group differences in functional connectivity.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="justify" rowspan="1" colspan="1"><bold>Contrast</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Seed (center of sphere)</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Target (peak coordinates)</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Cluster size (# voxels)</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Cluster p-FWE</bold></td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Controls &gt; IP</td><td valign="top" align="left" rowspan="1" colspan="1">Left thalamus (−7, −15,2)</td><td valign="top" align="left" rowspan="1" colspan="1">Left Somatosensory (−4, −27, 34)</td><td valign="top" align="center" rowspan="1" colspan="1">1873</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.000001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Right Somatosensory (6, −25, 42)</td><td valign="top" align="center" rowspan="1" colspan="1">973</td><td valign="top" align="center" rowspan="1" colspan="1">0.00006</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Right thalamus (8, −18, 5)</td><td valign="top" align="left" rowspan="1" colspan="1">Right Somatosensory (5, −26, 37)</td><td valign="top" align="center" rowspan="1" colspan="1">2373</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.000001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Left Somatosensory (−11, −26, 42)</td><td valign="top" align="center" rowspan="1" colspan="1">665</td><td valign="top" align="center" rowspan="1" colspan="1">0.00008</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Right insula (26, −2, 4)</td><td valign="top" align="left" rowspan="1" colspan="1">Right amygdala/hippocampus (14, −10, 15)</td><td valign="top" align="center" rowspan="1" colspan="1">871</td><td valign="top" align="center" rowspan="1" colspan="1">0.00007</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IP &gt; Controls</td><td valign="top" align="left" rowspan="1" colspan="1">Right thalamus (8, −18, 5)</td><td valign="top" align="left" rowspan="1" colspan="1">Right superior temporal gyrus (40, −19, 3)</td><td valign="top" align="center" rowspan="1" colspan="1">672</td><td valign="top" align="center" rowspan="1" colspan="1">0.00027</td></tr></tbody></table><table-wrap-foot><attrib><italic>Seed regions were defined <italic>post hoc</italic> based on results from the MVPA analysis. Target regions are labeled based on the locations of the largest number of voxels within significant cluster. All results are significant on a corrected cluster level (<italic>p</italic> &lt; 0.0005 FDR). Controls, non-invasive procedure group; IP, invasive procedure group.</italic></attrib></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Group differences in functional connectivity.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="justify">Contrast</td><td valign="top" align="left">Seed (center of sphere)</td><td valign="top" align="left">Target (peak coordinates)</td><td valign="top" align="center">Cluster size (# voxels)</td><td valign="top" align="center">Cluster p-FWE</td></tr></thead><tbody><tr><td valign="top" align="left">Controls &gt; IP</td><td valign="top" align="left">Left thalamus (−7, −15,2)</td><td valign="top" align="left">Left Somatosensory (−4, −27, 34)</td><td valign="top" align="center">1873</td><td valign="top" align="center">&lt;0.000001</td></tr><tr><td/><td/><td valign="top" align="left">Right Somatosensory (6, −25, 42)</td><td valign="top" align="center">973</td><td valign="top" align="center">0.00006</td></tr><tr><td/><td valign="top" align="left">Right thalamus (8, −18, 5)</td><td valign="top" align="left">Right Somatosensory (5, −26, 37)</td><td valign="top" align="center">2373</td><td valign="top" align="center">&lt;0.000001</td></tr><tr><td/><td/><td valign="top" align="left">Left Somatosensory (−11, −26, 42)</td><td valign="top" align="center">665</td><td valign="top" align="center">0.00008</td></tr><tr><td/><td valign="top" align="left">Right insula (26, −2, 4)</td><td valign="top" align="left">Right amygdala/hippocampus (14, −10, 15)</td><td valign="top" align="center">871</td><td valign="top" align="center">0.00007</td></tr><tr><td valign="top" align="left">IP &gt; Controls</td><td valign="top" align="left">Right thalamus (8, −18, 5)</td><td valign="top" align="left">Right superior temporal gyrus (40, −19, 3)</td><td valign="top" align="center">672</td><td valign="top" align="center">0.00027</td></tr></tbody></table></div>Seed regions were defined post hoc based on results from the MVPA analysis. Target regions are labeled based on the locations of the largest number of voxels within significant cluster. All results are significant on a corrected cluster level (p &lt; 0.0005 FDR). Controls, non-invasive procedure group; IP, invasive procedure group.</transformed-table></extracted-table></extracted-tables-set>